Monterola, Sherylann J.

HRN: 27-65-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2025
CEFUROXIME 1.5GM (VIAL)
08/16/2025
08/16/2025
IV
1.5g
1hr PTOR
For S&O
Remove - Pending Acceptance
08/16/2025
MUPIROCIN 2%, 15G (TUBE)
08/16/2025
08/23/2025
TOPICAL
Pea Sized
BID
S/P EL Salpingoophorectomy
Remove - Pending Acceptance
08/16/2025
CEFUROXIME 500MG (TAB)
08/16/2025
08/23/2025
PO
1 Tab
Q12h
S/P EL Salpingoophorectomy
Remove - Pending Acceptance
08/19/2025
CEFUROXIME 500MG (TAB)
08/19/2025
08/26/2025
PO
500mg
BID
SP ExLap Salpingoophorectomy
Remove - Pending Acceptance
08/19/2025
MUPIROCIN 2%, 15G (TUBE)
08/19/2025
08/26/2025
TOPICAL
2ml
BID
SP ExLap Salpingoophorectomy
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: